10.06
price up icon4.03%   0.39
after-market Dopo l'orario di chiusura: 10.34 0.28 +2.78%
loading

Arcus Biosciences Inc Borsa (RCUS) Ultime notizie

pulisher
Aug 12, 2025

Will Arcus Biosciences Inc. Hold Gains Into CloseReliable Alerts for Daily Stock Movers Released - beatles.ru

Aug 12, 2025
pulisher
Aug 10, 2025

Arcus Biosciences Q2 Earnings and Catalysts Ahead: A Risky Buy for 12 Months - AInvest

Aug 10, 2025
pulisher
Aug 10, 2025

Arcus BiosciencesA Risky Buy Ahead Of Pivotal, Catalyst Rich 12 Months (NYSE:RCUS) - Seeking Alpha

Aug 10, 2025
pulisher
Aug 09, 2025

Trapped Investors in Arcus Biosciences Inc. Await Breakout SignalNews Based Entry Opportunity Alerts Detected - beatles.ru

Aug 09, 2025
pulisher
Aug 09, 2025

Arcus Biosciences, Inc. (NYSE:RCUS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - Yahoo Finance

Aug 09, 2025
pulisher
Aug 09, 2025

Arcus Biosciences Inc. Stock Recovery Path — Analyst BreakdownReal Time Stock Movement Analysis Indicates Breakout - beatles.ru

Aug 09, 2025
pulisher
Aug 08, 2025

Gilead and Arcus Advance Promising Colorectal Cancer Study - TipRanks

Aug 08, 2025
pulisher
Aug 08, 2025

Arcus Biosciences Tops Revenue Forecasts And Drives Pipeline Growth - Finimize

Aug 08, 2025
pulisher
Aug 08, 2025

Gilead and Arcus Biosciences’ Promising Study on Advanced Gastrointestinal Cancers - TipRanks

Aug 08, 2025
pulisher
Aug 08, 2025

A Quick Look at Today's Ratings for Arcus Biosciences(RCUS.US), With a Forecast Between $14 to $52 - 富途牛牛

Aug 08, 2025
pulisher
Aug 08, 2025

Arcus Biosciences, Inc. (RCUS) Reports Break-Even Earnings for Q2 - MSN

Aug 08, 2025
pulisher
Aug 07, 2025

Wells Fargo Adjusts Price Target for Arcus Biosciences (RCUS) | - GuruFocus

Aug 07, 2025
pulisher
Aug 07, 2025

H.C. Wainwright Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $24 - 富途牛牛

Aug 07, 2025
pulisher
Aug 07, 2025

Morgan Stanley Lifts Price Target on Arcus Biosciences to $23 From $22, Keeps Overweight Rating - MarketScreener

Aug 07, 2025
pulisher
Aug 07, 2025

Decoding Arcus Biosciences Inc (RCUS): A Strategic SWOT Insight - GuruFocus

Aug 07, 2025
pulisher
Aug 07, 2025

Arcus Biosciences Reports Strong Q2 2025 Results - TipRanks

Aug 07, 2025
pulisher
Aug 06, 2025

Arcus Biosciences earnings beat by $0.01, revenue topped estimates - Investing.com Canada

Aug 06, 2025
pulisher
Aug 06, 2025

Arcus Biosciences Q2 revenue beats analyst expectations - MarketScreener

Aug 06, 2025
pulisher
Aug 06, 2025

Arcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline Update - Stock Titan

Aug 06, 2025
pulisher
Aug 05, 2025

Is Arcus Biosciences (NYSE:RCUS) Using Debt In A Risky Way? - 富途牛牛

Aug 05, 2025
pulisher
Aug 04, 2025

When is Arcus Biosciences Inc. stock expected to show significant growthIdentify undervalued stocks ready to soar - Jammu Links News

Aug 04, 2025
pulisher
Aug 03, 2025

How volatile is Arcus Biosciences Inc. stock compared to the marketTremendous gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the technical indicators suggesting about Arcus Biosciences Inc.Free Wealth Planning Blueprint - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Arcus Biosciences Inc. stockHigh-yield investments - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Arcus Biosciences Inc. stock in 2025Unlock powerful portfolio management tools - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Arcus Biosciences Inc. compare to its industry peersOutstanding capital appreciation - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for Arcus Biosciences Inc.Outstanding risk-reward balance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Why is Arcus Biosciences Inc. stock attracting strong analyst attentionRealize consistent double-digit growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does Arcus Biosciences Inc. stock perform well during market downturnsTremendous gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What catalysts could drive Arcus Biosciences Inc. stock higher in 2025Free Stock Movement Tracking - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

Arcus Biosciences’ Pancreatic Cancer Drug Quemliclustat Receives Orphan Drug Designation from FDA - MSN

Aug 01, 2025
pulisher
Aug 01, 2025

How does Arcus Biosciences Inc. generate profit in a changing economyPost Market Planner That Work - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

Arcus Biosciences Advances Phase 1 Study of AB521 in Cancer Treatment - TipRanks

Aug 01, 2025
pulisher
Jul 31, 2025

Will Arcus Biosciences Inc. bounce back from current supportEarly Breakout Entry Point Notifications Sent - metal.it

Jul 31, 2025
pulisher
Jul 31, 2025

Why Arcus Biosciences Inc. stock attracts strong analyst attentionConsistent Income Focused Trade List Analyzed - beatles.ru

Jul 31, 2025
pulisher
Jul 31, 2025

How many analysts rate Arcus Biosciences Inc. as a “Buy”Advanced Screener Report With Low Risk - Jammu Links News

Jul 31, 2025
pulisher
Jul 30, 2025

Arcus Biosciences’ Phase 3 Trial: A Potential Game-Changer in Pancreatic Cancer Treatment - TipRanks

Jul 30, 2025
pulisher
Jul 29, 2025

Arcus Biosciences Inc.’s Price Action Aligns with Quant SignalsHigh Yield Stock Screening Results Explained - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Arcus Biosciences’ SWOT analysis: HIF-2alpha program drives stock outlook By Investing.com - Investing.com South Africa

Jul 28, 2025
pulisher
Jul 28, 2025

Arcus Biosciences Inc. Shows Risk Reward Favoring UpsideReal Trader Watchlist of Hot Stocks Released - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Is it the right time to buy Arcus Biosciences Inc. stockSuperior returns - Jammu Links News

Jul 28, 2025
pulisher
Jul 28, 2025

What is Arcus Biosciences Inc. company’s growth strategyMaximize your portfolio’s growth potential - Jammu Links News

Jul 28, 2025
$36.46
price up icon 1.67%
$85.85
price up icon 5.20%
$26.87
price up icon 4.61%
$122.87
price up icon 0.71%
$112.78
price up icon 1.60%
biotechnology ONC
$307.51
price up icon 6.74%
Capitalizzazione:     |  Volume (24 ore):